Hortons Pharmacy
Hortons Pharmacy
  • News
By Hortons Pharmacy on Nov 01, 2025

Medivir and Biossil Team Up to Develop New Cancer Treatment

  • News
By Hortons Pharmacy on Oct 31, 2025

Simplifying Clinical Trials: Less Data Could Mean Better Results

  • News
By Hortons Pharmacy on Oct 30, 2025

Johnson & Johnson’s Big Changes: What It Means for Your Medicines

  • News
Hortons Pharmacy

Pfizer responded to a challenge from the investment firm Starboard by reporting better-than-expected financial results and raising their future earnings forecast.

Nov 16, 2024Dec 20, 2024
  • News
Hortons Pharmacy

Ultra-processed foods (UPFs) are contributing to a worrying increase in chronic diseases in India.

Nov 16, 2024Dec 20, 2024
  • News
Hortons Pharmacy

The UK health secretary warns people not to misuse GLP-1 medications just to look good for Instagram photos.

Nov 13, 2024Dec 20, 2024
  • News
Hortons Pharmacy

AbbVie has made a deal to buy the company Aliada for $1.4 billion.

Nov 13, 2024Dec 20, 2024
  • News
Hortons Pharmacy

Pfizer has chosen actor Patrick Dempsey to help guide cancer patients to the resources they need, aiming to improve patient support and care.

Nov 10, 2024Dec 20, 2024
  • News
Hortons Pharmacy

The European Commission has approved AstraZeneca’s drug Fasenra for the treatment of a condition called EGPA.

Nov 10, 2024Dec 20, 2024
  • News
Hortons Pharmacy

The fog lifts to reveal Parabilis, a newly rebranded cancer biotech company with support from well-known investors.

Nov 07, 2024Dec 20, 2024
  • News
Hortons Pharmacy

U.S. Border Protection is alerting pharmaceutical companies about the dangers of importing biological products incorrectly.

Nov 07, 2024Dec 20, 2024
  • News
Hortons Pharmacy

Novartis and Apellis are competing to get their treatments approved for a rare kidney disease. They have both released new data related to their drugs as part of this race.

Nov 04, 2024Feb 27, 2025
  • News
Hortons Pharmacy

Bavarian is looking to expand the use of the Mpox vaccine to include toddlers. They are starting a Phase II trial to test this.

Nov 04, 2024Dec 20, 2024
Previous Page 1 of 6 … Page 5 of 6 Page 6 of 6 Next
View Desktop Version